Lewati ke isi utama
  • Sign in
    Welcome !
    My account
    Logout

CONMED Corp (CNMD) Stock Forecast 2025 - AI Price Prediction & Analysis

CONMED Corp (CNMD) AI Stock Price Forecast & Investment Analysis

CONMED Corp Stock Price Chart and Technical Analysis

Loading CONMED Corp interactive price chart and technical analysis...

CONMED Corp (CNMD) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

CONMED Corp (Stock Symbol: CNMD) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry. The organization employs approximately 2713 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $1326 million generating a 10,2% net profit margin .

Market Capitalization: $1627 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 8,9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CONMED Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

CONMED Corp strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company demonstrates robust operational efficiency through strong free cash flow generation of $74 million annually , complemented by impressive -32,2% year-over-year cash flow growth The company maintains a healthy 55,7% gross margin, indicating strong pricing power and operational efficiency.

CONMED Corp (CNMD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CONMED Corp stock analysis.

Loading CONMED Corp comprehensive fundamental analysis and insider trading data...

Deep dive into CONMED Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CONMED Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CONMED Corp: With a P/E ratio of 14,76, the market sees the stock as potentially undervalued.

P/E Ratio 14,76x
P/B Ratio 1,62x
Market Cap $1627M
Dividend Yield 0,01%
EPS $3,57
Book Value/Share $32,21
Revenue/Share $42,59
FCF/Share $2,40
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CONMED Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CONMED Corp: An ROE of 8,9% indicates room for improvement in shareholder value creation.

ROE 8,9%
ROA 3,8%
ROIC 6,2%
Gross Margin 55,7%
Operating Margin 15,4%
Net Margin 10,2%
EBT Margin 7,9%
Tax Rate 16,3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CONMED Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CONMED Corp: A current ratio of 2,60 indicates strong liquidity.

Current Ratio 2,60x
Quick Ratio 1,11x
D/E Ratio 0,89x
Financial Leverage 2,26x
Interest Coverage 3,7x
Working Capital $226M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CONMED Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CONMED Corp: Free cash flow of $74M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $90M
Free Cash Flow $74M
Capital Spending $-15M
OCF Growth YoY -32,2%
FCF Growth YoY -31,4%
FCF/Sales 7,3%
CapEx/Sales 1,5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CONMED Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CONMED Corp: An asset turnover of 0,58x suggests room for improvement in asset utilization.

Asset Turnover 0,58x
Receivables Turnover 5,9x
Inventory Turnover 1,9x
Fixed Assets Turnover 9,4x
Days Sales Outstanding 62 days
Days Inventory 189 days
Payables Period 51 days
Cash Conversion Cycle 200 days
Understanding Financial Statement Data

What these metrics mean: Key figures from CONMED Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CONMED Corp: With annual revenue of $1326M, CONMED Corp operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1326M
R&D Expense $55M
SG&A Expense $41M
Cost of Goods Sold $571M
Balance Sheet Highlights ($ Millions)
Total Current Assets $27M
Cash & Short-term Investments $1M
Total Liabilities $56M
Short-term Debt $1M
Accounts Receivable $10M
Inventory $14M
Dividend & Shareholder Information
Dividends Per Share $0,40
Payout Ratio 0,1%
Shares Outstanding 31M
Growth Metrics (YoY)
EPS Growth 6,3%

Latest CONMED Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CONMED Corp (CNMD) stock price and investment outlook.

, source: Morningstar

CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 20, 2025, payable on July 3, 2025, to all shareholders of ...

, source: FierceBiotech

UTICA, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- CONMED Corporation (Nasdaq:CNMD) today announced that Joseph Corasanti is stepping down as Chief Executive Officer, President and a member of the ...

CONMED Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of CONMED Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast $739M -41,7x 6,6x
BLFS Unlock Forecast $991M -14,7x 2,8x
BSGM Unlock Forecast $126M -1,8x 48,5x
CBLL Unlock Forecast $433M x 2,5x
CNMD Unlock Forecast $1627M 14,8x 1,6x
CUTR Unlock Forecast $9M -0,1x 0,0x
CV Unlock Forecast $0M x x
ECOR Unlock Forecast $40M -7,3x 35,6x
EDAP Unlock Forecast $85M x 2,1x
ELMD Unlock Forecast $220M 29,3x 5,1x
FONR Unlock Forecast $101M 9,8x 0,6x
GTHP Unlock Forecast $22M x x
HSDT Unlock Forecast $66M 0,0x 51,9x
HYPR Unlock Forecast $148M -1,8x 0,9x
INMD Unlock Forecast $1204M x 1,7x
IRIX Unlock Forecast $23M -2,8x 3,7x
IRME Unlock Forecast $1M x x
ITGR Unlock Forecast $3833M 46,4x 2,3x
LIVN Unlock Forecast $3107M -662,0x 2,8x
MASI Unlock Forecast $7562M 128,1x 7,3x
MDT Unlock Forecast $119330M 25,6x 2,5x
MOVE Unlock Forecast $5M -8,6x 0,7x
NDRA Unlock Forecast $2M -0,8x 1,1x
NRXS Unlock Forecast $25M -0,9x 5,9x
NUWE Unlock Forecast $65M -0,1x 18,1x
NXL Unlock Forecast $17M -4,7x 2,8x
NXLIW Unlock Forecast $5M x 1,0x
OM Unlock Forecast $247M -0,4x 1,6x
POCI Unlock Forecast $36M -11,5x 2,8x
QTI Unlock Forecast $7M -0,4x -0,8x
SLNO Unlock Forecast $4417M -18,5x 19,0x
SMLR Unlock Forecast $406M 11,0x 1,1x
STRR Unlock Forecast $7M -1,6x 0,1x
STRRP Unlock Forecast $31M -5,5x 0,5x
STXS Unlock Forecast $1173M -8,4x 805,9x
TIVC Unlock Forecast $3M 0,0x 0,8x
TMDX Unlock Forecast $4489M 62,6x 14,1x
VANI Unlock Forecast $92M -2,7x 7,9x
VASO Unlock Forecast $23M 20,1x 0,9x
ZYXI Unlock Forecast $51M 41,4x 40,2x

Frequently Asked Questions - CONMED Corp Stock Forecast

How accurate are CONMED Corp stock predictions?

Our AI model demonstrates 65% historical accuracy for CNMD predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence CONMED Corp stock price forecasts?

Our analysis considers CONMED Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CONMED Corp a good investment in 2025?

Based on our AI analysis, CONMED Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CONMED Corp forecasts updated?

CONMED Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CONMED Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CONMED Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...